Provided by Tiger Trade Technology Pte. Ltd.

Myriad Genetics

3.18
-0.0400-1.24%
Post-market: 3.190.0100+0.31%17:25 EDT
Volume:3.03M
Turnover:9.30M
Market Cap:304.01M
PE:-2.64
High:3.22
Open:2.95
Low:2.92
Close:3.22
52wk High:8.59
52wk Low:2.74
Shares:95.60M
Float Shares:79.40M
Volume Ratio:2.08
T/O Rate:3.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2031
EPS(LYR):-3.9514
ROE:-32.54%
ROA:-8.59%
PB:1.00
PE(LYR):-0.80

Loading ...

Myriad Genetics director Rashmi Kumar sells 15,000 shares worth $66,843

Reuters
·
Jun 10

Myriad Genetics Holds 2026 Annual Meeting and Approves Plans

TIPRANKS
·
Jun 05

Myriad Genetics shareholders approve 4 million-share increase to employee stock purchase plan

Reuters
·
Jun 05

Press Release: Myriad Genetics Names Raj Jampa as New Chief Technology Officer

Dow Jones
·
Jun 02

Myriad Genetics reports interim MONSTAR-SCREEN-3 data showing Precise MRD test prognostic value across cancers at ASCO 2026

Reuters
·
May 27

Myriad Genetics launches Prolaris + AI prostate cancer test combining genomics, digital pathology AI

Reuters
·
May 27

Myriad Genetics Launches Prolaris® + AI, the First Prostate Cancer Test to Combine Genomics and Digital Pathology Artificial Intelligence (AI)

THOMSON REUTERS
·
May 27

MindWalk Holdings Leads Our Trio Of Promising Penny Stocks

Simply Wall St.
·
May 23

Actress Jackie Tohn Got Results Nobody Wants But They May Have Saved Her Life

GlobeNewswire
·
May 15

Myriad Genetics Director Paul Bisaro acquires 7,500 shares for $27,637.50

Reuters
·
May 15

Myriad Genetics to join Goldman Sachs Global Healthcare Conference fireside chat

Reuters
·
May 08

Myriad Genetics price target lowered to $6 from $7 at TD Cowen

TIPRANKS
·
May 07

Myriad Genetics Bets on Growth Amid Profit Squeeze

TIPRANKS
·
May 07

Myriad Genetics Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
May 06

Piper Sandler Reaffirms Their Buy Rating on Myriad Genetics (MYGN)

TIPRANKS
·
May 06

Analysts Offer Insights on Healthcare Companies: Myriad Genetics (MYGN) and Dianthus Therapeutics (DNTH)

TIPRANKS
·
May 06

Analysts Offer Insights on Healthcare Companies: Myriad Genetics (MYGN) and Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF)

TIPRANKS
·
May 06

Myriad Genetics Q1 revenue growth misses estimates

Reuters
·
May 06

Myriad Genetics Q1 Adj. EPS $(0.09) Misses $(0.07) Estimate, Sales $200.400M Miss $202.484M Estimate

Benzinga Earnings
·
May 06

BRIEF-Myriad Genetics Q1 EPS USD -0.36

Reuters
·
May 06